通过 Mi-thos 系统进行过导管中枢替换:这是人类的首次体验
Ye Yang1, Jinmiao Chen1, Lili Dong2
1Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
概括
使用Mi-thos系统进行透导管关节置换 (TMVR) 对患有严重关节吐 (MR) 的高风险患者来说是安全和可行的. 短期结果显示植入成功,没有重大并发症,表明有前途的替代疗法.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 严重的额叶吐 (MR) 对高风险患者构成重大风险.
- 过导管 mitra 置换 (TMVR) 正在成为一种不那么侵入性的替代方案.
- 评估新的TMVR系统对于扩大治疗选择至关重要.
研究的目的:
- 评估Mi-thosTMVR系统的安全性和可行性.
- 在患有严重MR的高风险患者中评估Mi-thos系统.
- 为了确定Mi-thos系统在现实世界临床环境中的有效性.
主要方法:
- 前性,双中心,单臂早期可行性研究.
- 招募了十名患有严重MR的高风险患者.
- 评估手术成功,30天死亡率和重大并发症.
主要成果:
- 在所有10名患者中,成功地将Mi-thosTMVR系统通过跨吸管接入植入所有10名患者.
- 在手术后30天内,没有手术死亡率或重大并发症.
- 优秀的门功能,没有或微小的反和植入后的低梯度.
结论:
- 米索斯TMVR系统在短期内显示出良好的安全性和可行性.
- 该系统显示出作为高风险重症MR患者的治疗替代方案的潜力.
- 需要对Mi-thosTMVR系统进行进一步的调查和长期评估.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


